表紙
市場調查報告書
商品編碼
1064464

中樞神經系統(CNS)刺激藥的全球市場:2022∼2026年

Global Central Nervous System (CNS) Stimulant Drugs Market 2022-2026

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球中樞神經系統(CNS)刺激藥的市場規模在2022年∼2026年間,預測將成長到59億5,000萬美元,在預測期間內年複合成長率預計將為5.74%。

市場成長的主要因素有CNS疾病的增加,新型興奮劑的認證,全球興奮劑的使用增加。

本報告提供全球中樞神經系統(CNS)刺激藥市場相關調查分析,提供市場規模,波特的五力分析,各用途市場市場區隔,客戶形勢,地區形勢,業者情勢,供應商分析等資訊。

目錄

第1章 摘要整理

  • 市場概要

第2章 市場形勢

  • 市場生態系統

第3章 市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模:2021年
  • 市場預測:預測(2021∼2026年)

第4章 波特的五力分析

  • 五力的摘要
  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 對手的威脅
  • 市場情況

第5章 市場區隔:各用途

  • 市場區隔
  • 比較:各用途
  • 注意力不足過動症:市場規模與預測(2021∼2026年)
  • 猝睡症:市場規模與預測(2021∼2026年)
  • 其他:市場規模與預測(2021∼2026年)
  • 市場機會:各用途

第6章 客戶形勢

  • 客戶形勢概要

第7章 地區形勢

  • 地區市場區隔
  • 比較:各地區
  • 北美:市場規模與預測(2021∼2026年)
  • 歐洲:市場規模與預測(2021∼2026年)
  • 亞洲:市場規模與預測(2021∼2026年)
  • 其他地區(ROW):市場規模與預測(2021∼2026年)
  • 美國:市場規模與預測(2021∼2026年)
  • 加拿大:市場規模與預測(2021∼2026年)
  • 英國:市場規模與預測(2021∼2026年)
  • 德國:市場規模與預測(2021∼2026年)
  • 中國:市場規模與預測(2021∼2026年)
  • 墨西哥:市場規模與預測(2021∼2026年)
  • 市場機會:各地區形勢

第8章 促進因素,課題,及趨勢

  • 市場促進因素
  • 市場課題
  • 推動因素與課題的影響
  • 市場趨勢

第9章 業者情勢

  • 概要
  • 業者情勢
  • 創新的形勢
  • 產業的風險

第10章 供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Biogen Inc.
  • Endo International Plc
  • GlaxoSmithKline Plc
  • Johnson and Johnson Inc.
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.

第11章 附錄

  • 調查範圍
  • 納入和排除清單
  • 貨幣換算比率(美元)
  • 調查手法
  • 簡稱的清單
目錄
Product Code: IRTNTR72695

Technavio has been monitoring the central nervous system (CNS) stimulant drugs market and it is poised to grow by $ 5.95 bn during 2022-2026, progressing at a CAGR of 5.74% during the forecast period. Our report on the central nervous system (CNS) stimulant drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in CNS disorders, approval of new stimulants, and increasing use of stimulants worldwide. In addition, a rise in CNS disorders is anticipated to boost the growth of the market as well.

The central nervous system (CNS) stimulant drugs market analysis includes application segment and geographic landscape.

Technavio's central nervous system (CNS) stimulant drugs market is segmented as below:

By Application

  • Attention-deficit hyperactivity disorder
  • Narcolepsy
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the increased uptake of new-generation drugs as one of the prime reasons driving the central nervous system (CNS) stimulant drugs market growth during the next few years. Also, the rising demand to legalize cannabis worldwide, and increasing repurposing of drugs will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the central nervous system (CNS) stimulant drugs market covers the following areas:

  • Central nervous system (CNS) stimulant drugs market sizing
  • Central nervous system (CNS) stimulant drugs market forecast
  • Central nervous system (CNS) stimulant drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading central nervous system (CNS) stimulant drugs market vendors that include Astellas Pharma Inc., Biogen Inc., Endo International Plc, GlaxoSmithKline Plc, Highland Therapeutics Inc., Jazz Pharmaceuticals Plc, Johnson and Johnson Inc., KemPharm Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma LP, Sanofi SA, SHIONOGI Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., Tris Pharma Inc., UCB SA, and Viatris Inc. Also, the central nervous system (CNS) stimulant drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

  • 5.1 Market segments
  • Exhibit 24: Chart on Application - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
  • 5.2 Comparison by Application
  • Exhibit 26: Chart on Comparison by Application
  • Exhibit 27: Data Table on Comparison by Application
  • 5.3 Attention-deficit hyperactivity disorder - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Attention-deficit hyperactivity disorder - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Attention-deficit hyperactivity disorder - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Attention-deficit hyperactivity disorder - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Attention-deficit hyperactivity disorder - Year-over-year growth 2021-2026 (%)
  • 5.4 Narcolepsy - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Narcolepsy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Narcolepsy - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Narcolepsy - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Narcolepsy - Year-over-year growth 2021-2026 (%)
  • 5.5 Others - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • 5.6 Market opportunity by Application
  • Exhibit 40: Market opportunity by Application ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 44: Chart on Geographic comparison
  • Exhibit 45: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Canada - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.9 UK - Market size and forecast 2021-2026
  • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.10 Germany - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.11 China - Market size and forecast 2021-2026
  • Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.12 Mexico - Market size and forecast 2021-2026
  • Exhibit 82: Chart on Mexico - Market size and forecast 2021-2026 ($ million)
  • Exhibit 83: Data Table on Mexico - Market size and forecast 2021-2026 ($ million)
  • Exhibit 84: Chart on Mexico - Year-over-year growth 2021-2026 (%)
  • Exhibit 85: Data Table on Mexico - Year-over-year growth 2021-2026 (%)
  • 7.13 Market opportunity By Geographical Landscape
  • Exhibit 86: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 87: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 89: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 90: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 91: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 92: Matrix on vendor position and classification
  • 10.3 Biogen Inc.
  • Exhibit 93: Biogen Inc. - Overview
  • Exhibit 94: Biogen Inc. - Product / Service
  • Exhibit 95: Biogen Inc. - Key offerings
  • 10.4 Endo International Plc
  • Exhibit 96: Endo International Plc - Overview
  • Exhibit 97: Endo International Plc - Business segments
  • Exhibit 98: Endo International Plc - Key news
  • Exhibit 99: Endo International Plc - Key offerings
  • Exhibit 100: Endo International Plc - Segment focus
  • 10.5 GlaxoSmithKline Plc
  • Exhibit 101: GlaxoSmithKline Plc - Overview
  • Exhibit 102: GlaxoSmithKline Plc - Business segments
  • Exhibit 103: GlaxoSmithKline Plc - Key news
  • Exhibit 104: GlaxoSmithKline Plc - Key offerings
  • Exhibit 105: GlaxoSmithKline Plc - Segment focus
  • 10.6 Johnson and Johnson Inc.
  • Exhibit 106: Johnson and Johnson Inc. - Overview
  • Exhibit 107: Johnson and Johnson Inc. - Business segments
  • Exhibit 108: Johnson and Johnson Inc. - Key news
  • Exhibit 109: Johnson and Johnson Inc. - Key offerings
  • Exhibit 110: Johnson and Johnson Inc. - Segment focus
  • 10.7 Merck and Co. Inc.
  • Exhibit 111: Merck and Co. Inc. - Overview
  • Exhibit 112: Merck and Co. Inc. - Business segments
  • Exhibit 113: Merck and Co. Inc. - Key news
  • Exhibit 114: Merck and Co. Inc. - Key offerings
  • Exhibit 115: Merck and Co. Inc. - Segment focus
  • 10.8 Novartis AG
  • Exhibit 116: Novartis AG - Overview
  • Exhibit 117: Novartis AG - Business segments
  • Exhibit 118: Novartis AG - Key offerings
  • Exhibit 119: Novartis AG - Segment focus
  • 10.9 Pfizer Inc.
  • Exhibit 120: Pfizer Inc. - Overview
  • Exhibit 121: Pfizer Inc. - Product / Service
  • Exhibit 122: Pfizer Inc. - Key news
  • Exhibit 123: Pfizer Inc. - Key offerings
  • 10.10 Sanofi SA
  • Exhibit 124: Sanofi SA - Overview
  • Exhibit 125: Sanofi SA - Business segments
  • Exhibit 126: Sanofi SA - Key news
  • Exhibit 127: Sanofi SA - Key offerings
  • Exhibit 128: Sanofi SA - Segment focus
  • 10.11 Takeda Pharmaceutical Co. Ltd.
  • Exhibit 129: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibit 130: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibit 131: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibit 132: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • 10.12 Teva Pharmaceutical Industries Ltd.
  • Exhibit 133: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibit 134: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibit 135: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibit 136: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibit 137: Teva Pharmaceutical Industries Ltd. - Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 138: Inclusions checklist
  • Exhibit 139: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 140: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 141: Research methodology
  • Exhibit 142: Validation techniques employed for market sizing
  • Exhibit 143: Information sources
  • 11.5 List of abbreviations
  • Exhibit 144: List of abbreviations

Exhibits

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Application - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Application - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Application
  • Exhibits27: Data Table on Comparison by Application
  • Exhibits28: Chart on Attention-deficit hyperactivity disorder - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Attention-deficit hyperactivity disorder - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Attention-deficit hyperactivity disorder - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Attention-deficit hyperactivity disorder - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Narcolepsy - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Narcolepsy - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Narcolepsy - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Narcolepsy - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Chart on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibits37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibits38: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits39: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits40: Market opportunity by Application ($ million)
  • Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits44: Chart on Geographic comparison
  • Exhibits45: Data Table on Geographic comparison
  • Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits79: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits80: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Chart on Mexico - Market size and forecast 2021-2026 ($ million)
  • Exhibits83: Data Table on Mexico - Market size and forecast 2021-2026 ($ million)
  • Exhibits84: Chart on Mexico - Year-over-year growth 2021-2026 (%)
  • Exhibits85: Data Table on Mexico - Year-over-year growth 2021-2026 (%)
  • Exhibits86: Market opportunity By Geographical Landscape ($ million)
  • Exhibits87: Impact of drivers and challenges in 2021 and 2026
  • Exhibits88: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits89: Overview on factors of disruption
  • Exhibits90: Impact of key risks on business
  • Exhibits91: Vendors covered
  • Exhibits92: Matrix on vendor position and classification
  • Exhibits93: Biogen Inc. - Overview
  • Exhibits94: Biogen Inc. - Product / Service
  • Exhibits95: Biogen Inc. - Key offerings
  • Exhibits96: Endo International Plc - Overview
  • Exhibits97: Endo International Plc - Business segments
  • Exhibits98: Endo International Plc - Key news
  • Exhibits99: Endo International Plc - Key offerings
  • Exhibits100: Endo International Plc - Segment focus
  • Exhibits101: GlaxoSmithKline Plc - Overview
  • Exhibits102: GlaxoSmithKline Plc - Business segments
  • Exhibits103: GlaxoSmithKline Plc - Key news
  • Exhibits104: GlaxoSmithKline Plc - Key offerings
  • Exhibits105: GlaxoSmithKline Plc - Segment focus
  • Exhibits106: Johnson and Johnson Inc. - Overview
  • Exhibits107: Johnson and Johnson Inc. - Business segments
  • Exhibits108: Johnson and Johnson Inc. - Key news
  • Exhibits109: Johnson and Johnson Inc. - Key offerings
  • Exhibits110: Johnson and Johnson Inc. - Segment focus
  • Exhibits111: Merck and Co. Inc. - Overview
  • Exhibits112: Merck and Co. Inc. - Business segments
  • Exhibits113: Merck and Co. Inc. - Key news
  • Exhibits114: Merck and Co. Inc. - Key offerings
  • Exhibits115: Merck and Co. Inc. - Segment focus
  • Exhibits116: Novartis AG - Overview
  • Exhibits117: Novartis AG - Business segments
  • Exhibits118: Novartis AG - Key offerings
  • Exhibits119: Novartis AG - Segment focus
  • Exhibits120: Pfizer Inc. - Overview
  • Exhibits121: Pfizer Inc. - Product / Service
  • Exhibits122: Pfizer Inc. - Key news
  • Exhibits123: Pfizer Inc. - Key offerings
  • Exhibits124: Sanofi SA - Overview
  • Exhibits125: Sanofi SA - Business segments
  • Exhibits126: Sanofi SA - Key news
  • Exhibits127: Sanofi SA - Key offerings
  • Exhibits128: Sanofi SA - Segment focus
  • Exhibits129: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibits130: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibits131: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibits132: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Exhibits133: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibits134: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibits135: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibits136: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits137: Teva Pharmaceutical Industries Ltd. - Segment focus
  • Exhibits138: Inclusions checklist
  • Exhibits139: Exclusions checklist
  • Exhibits140: Currency conversion rates for US$
  • Exhibits141: Research methodology
  • Exhibits142: Validation techniques employed for market sizing
  • Exhibits143: Information sources
  • Exhibits144: List of abbreviations